GILD Stock Recent News Gilead Sciences (GILD) 106.45 11/09/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 11:42 AM

Gilead Sciences (GILD) 106.45 $GILD

5 Prescription Drugs Selling Like Hot Cakes
Todd Campbell, The Motley Fool - Motley Fool - 1 hr 41 mins ago
Considering that 90% of prescription drugs being developed by biotechnology companies will fail during clinical trials, it can be tough to know which biotech stocks to seize upon and which stocks to shun. Instead of focusing on unproven...
MDVN: 112.77 (+7.82), JNJ: 108.20 (-0.81), BIIB: 320.75 (-2.72), PTLA: 27.39 (-0.33), GILD: 106.45 (-0.49), CELG: 106.45 (-0.69)

3 Biotech Stocks to Watch in November
Motley Fool Staff - Motley Fool - Sat Nov 08, 10:03AM CST
Investing in biotech companies can be tricky, especially for investors who don't have a scientific background or who don't completely understand the process of bringing new drugs to the marketplace. Fortunately, the Fool is here to help. We asked...
AVNR: 13.02 (-0.19), SGEN: 36.05 (+1.20), GILD: 106.45 (-0.49), ABBV: 61.50 (-1.21), GSK: 44.91 (+0.16)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 23.13 (+0.19), KMI: 38.75 (+0.22), HK: 3.24 (+0.34), KSS: 57.22 (+0.41), GE: 26.41 (+0.05), LMT: 186.15 (-3.73), AVAV: 29.81 (-0.65), WMT: 78.77 (+0.96), SNE: 19.62 (-0.08), M: 59.88 (+0.84), SDRL: 21.77 (+0.06), T: 34.91 (+0.19), W: 26.01 (+0.31), OPK: 8.32 (-0.10), QCOM: 69.26 (-1.32), TWTR: 40.31 (-0.53), EPR: 56.61 (+0.23), AAPL: 109.01 (+0.31), HSIC: 128.84 (-1.47), CSCO: 25.33 (+0.07), WFM: 46.81 (+1.96), CY: 10.08 (-0.02), MU: 33.01 (-0.34), SWKS: 59.88 (-2.26), IRM: 38.05 (+1.58), BAC: 17.36 (unch), MO: 49.87 (+0.31), CSX: 35.45 (+0.32), WWAV: 36.93 (-0.53), GILD: 106.45 (-0.49), TXN: 50.90 (unch), BPL: 79.30 (+1.86), JCP: 7.82 (+0.34), JWN: 73.43 (-0.25), BABA: 114.56 (+2.99)

Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 5:50PM CST
Gilead Sciences, Inc. announced that it has submitted a New Drug Application to the FDA for its tenofovir alafenamide-based single tablet regimen.
AGN: 196.00 (-1.40), JNJ: 108.20 (-0.81), GILD: 106.45 (-0.49), ABBV: 61.50 (-1.21)

Final Glance: Biotechnology companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)

Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig
Todd Campbell, The Motley Fool - Motley Fool - Fri Nov 07, 12:42PM CST
Source: Pharmacyclics Peak sales forecasts for Pharmacyclics' Imbruvica are estimated north of $3 billion, but investors had reason for pause last quarter when competitor Gilead Sciences launched Zydelig for the same indication. ...
JNJ: 108.20 (-0.81), PCYC: 133.49 (-3.63), GILD: 106.45 (-0.49), AZN: 72.88 (+0.03), GSK: 44.91 (+0.16), BMY: 58.32 (-0.14), CELG: 106.45 (-0.69)

Midday Glance: Biotechnology companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014
Marketwire Canada - Fri Nov 07, 9:56AM CST
Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that it will be broadcast on both the BNN and the Fox Business News Network by Taylor Thoen, Executive Producer of BTV-Business TV. This broadcast will be a segment of the episode that will feature Gilead Sciences, Cynapsus Therapeutics, and biOasis Technologies Inc.
GILD: 106.45 (-0.49), MFS.VN: 0.085 (-0.005)

Early Glance: Biotechnology companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)

Humana Misses On ObamaCare Spending, Hep C Costs
at Investor's Business Daily - Fri Nov 07, 9:32AM CST
Humana (HUM) narrowed its earnings outlook for the year as its third-quarter revenue and earnings views fell short of analyst expectations on insurance and hepatitis C-related costs. Full-year earnings guidance is now in the range of $7.40-$7.60 per...
GILD: 106.45 (-0.49), AET: 82.29 (-2.41), HUM: 130.58 (-9.29)

Gilead Sciences (GILD) Crosses Pivot Point Resistance at $108.23
Comtex SmarTrend(R) - Fri Nov 07, 8:58AM CST
Shares of Gilead Sciences (NASDAQ:GILD) opened today above their pivot of $107.16 and have already reached the first level of resistance at $108.23. Analysts will be watching for a cross of the next upside pivot targets of $109.51 and $111.86.
GILD: 106.45 (-0.49)

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
George Budwell, The Motley Fool - Motley Fool - Fri Nov 07, 7:45AM CST
The patent cliff might have decimated revenues in the world of Big Pharma, but it has also led to an unprecedented level of innovation within the industry. In the coming years, for example, we should see four to five new types of drugs that are...
JNJ: 108.20 (-0.81), ESRX: 77.87 (-0.05), GILD: 106.45 (-0.49), ABBV: 61.50 (-1.21), BMY: 58.32 (-0.14), ENTA: 43.33 (-0.17)

Linkage Biosciences Adds to Board Leadership
Marketwired - Fri Nov 07, 7:02AM CST
Linkage Biosciences, a leading manufacturer of tissue transplantation diagnostic products, announced the election of Mr. Lewis J. Stuart to the company's Board of Directors. The election reflects Linkage's continued focus on expansion in both domestic and international markets.
GILD: 106.45 (-0.49), GHDX: 35.81 (+0.72)

5 Things AbbVie Inc.'s Management Wants You to Know
Keith Speights, The Motley Fool - Motley Fool - Thu Nov 06, 11:38AM CST
Another quarter for AbbVie , another blow-out. The company announced strong third-quarter results last Friday. AbbVie's storyline behind those earnings, though, is probably more important than the numbers themselves. Here are five things the...
ABT: 43.37 (-0.32), GILD: 106.45 (-0.49), ABBV: 61.50 (-1.21)

Why Achillion Pharmaceuticals, Inc. Stock Launched 18% Higher in October
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 06, 8:40AM CST
ACHN data by YCharts What: Shares of Achillion Pharmaceuticals , a clinical-stage biopharmaceutical company focused on developing therapies to treat hepatitis C and other chronic bacterial infections, launched higher by 18% during the month...
GILD: 106.45 (-0.49), ACHN: 10.11 (-0.15)

Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver
PR Newswire - Thu Nov 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for DAL, COP, QCOM, KMI and GILD.
KMI: 38.75 (+0.22), GILD: 106.45 (-0.49), DAL: 42.69 (-0.21), QCOM: 69.26 (-1.32), COP: 72.16 (+0.84)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kansas Marijuana DUI Laws: What Drivers Must Know

Navigating the Legal Maze of Marijuana DUIs Marijuana DUI, ever heard of it? Many folks in Kansas might just find themselves scratching their heads. While booze clearly shouts 'DUI' when you hit the road sauced, the green stuff doesn’t dodge that same bullet. You better believe it, Kansas doesn’t mess around when it comes to drugs behind the wheel, and marijuana is...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...

Craig Hospital Expands: A Milestone for Rehab Care

A Bold Step Forward in Neurorehabilitation Over a September sky in Englewood, Colorado, a ceremonial beam rose, marking a major milestone for Craig Hospital. It's not just steel and concrete; it's hope and progress for many who've found themselves at the mercy of neurological injuries. Celebrating the 'topping out' of their expanded campus, Craig's latest step forward...

NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

RiskScout Rides High on Funding, Tackles Financial Crime

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

AHN Healthcare@Home Celebrates Fourth Top Workplace Win

Four-Time Top Workplace Champ You want to talk consistency? Let's talk about AHN Healthcare@Home pulling in that Pittsburgh Top Workplace award four years running. It's no small feat, especially in the healthcare sector where employee burnout isn't just a buzzword—it's a daily challenge. How did a home health and hospice outfit like AHN land this honor? Well, it's all...

Class Action Lawsuit Hits Desert Resort Management

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

Colson Group Expands with Algood Acquisition

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Appy Pie Secures Patent for AI Driven App Building

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...